BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

274 related articles for article (PubMed ID: 16329683)

  • 1. Association between the polycystic ovary syndrome and the metabolic syndrome in Puerto Rico.
    Rabelo Acevedo M; Vick MR
    P R Health Sci J; 2005 Sep; 24(3):203-6. PubMed ID: 16329683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metabolic syndrome in polycystic ovary syndrome.
    Carmina E
    Minerva Ginecol; 2006 Apr; 58(2):109-14. PubMed ID: 16582867
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolic and cardiovascular consequences of polycystic ovary syndrome.
    Orio F; Vuolo L; Palomba S; Lombardi G; Colao A
    Minerva Ginecol; 2008 Feb; 60(1):39-51. PubMed ID: 18277351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The metabolic syndrome in young Korean women with polycystic ovary syndrome.
    Park HR; Choi Y; Lee HJ; Oh JY; Hong YS; Sung YA
    Diabetes Res Clin Pract; 2007 Sep; 77 Suppl 1():S243-6. PubMed ID: 17610984
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Type 2 diabetes and the polycystic ovary syndrome.
    Pelusi B; Gambineri A; Pasquali R
    Minerva Ginecol; 2004 Feb; 56(1):41-51. PubMed ID: 14973409
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polycystic ovary syndrome in the Indian Subcontinent.
    Allahbadia GN; Merchant R
    Semin Reprod Med; 2008 Jan; 26(1):22-34. PubMed ID: 18181079
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differences in low-grade chronic inflammation and insulin resistance in women with previous gestational diabetes mellitus and women with polycystic ovary syndrome.
    Thomann R; Rossinelli N; Keller U; Tirri BF; De Geyter C; Ruiz J; Kränzlin M; Puder JJ
    Gynecol Endocrinol; 2008 Apr; 24(4):199-206. PubMed ID: 18382906
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiovascular risks and metabolic syndrome in Hong Kong Chinese women with polycystic ovary syndrome.
    Cheung LP; Ma RC; Lam PM; Lok IH; Haines CJ; So WY; Tong PC; Cockram CS; Chow CC; Goggins WB
    Hum Reprod; 2008 Jun; 23(6):1431-8. PubMed ID: 18359783
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of the metabolic syndrome in German women with polycystic ovary syndrome.
    Hahn S; Tan S; Sack S; Kimmig R; Quadbeck B; Mann K; Janssen OE
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):130-5. PubMed ID: 17318774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence of the metabolic syndrome and its components in Brazilian women with polycystic ovary syndrome.
    Soares EM; Azevedo GD; Gadelha RG; Lemos TM; Maranhão TM
    Fertil Steril; 2008 Mar; 89(3):649-55. PubMed ID: 17543961
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Obesity, free testosterone, and cardiovascular risk factors in adolescents with polycystic ovary syndrome and regularly cycling adolescents.
    Glueck CJ; Morrison JA; Friedman LA; Goldenberg N; Stroop DM; Wang P
    Metabolism; 2006 Apr; 55(4):508-14. PubMed ID: 16546482
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolic syndrome in young Czech women with polycystic ovary syndrome.
    Vrbíková J; Vondra K; Cibula D; Dvoráková K; Stanická S; Srámková D; Sindelka G; Hill M; Bendlová B; Skrha J
    Hum Reprod; 2005 Dec; 20(12):3328-32. PubMed ID: 16085666
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The evaluation of metabolic parameters and insulin sensitivity for a more robust diagnosis of the polycystic ovary syndrome.
    Amato MC; Galluzzo A; Finocchiaro S; Criscimanna A; Giordano C
    Clin Endocrinol (Oxf); 2008 Jul; 69(1):52-60. PubMed ID: 18034780
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An association between non-alcoholic fatty liver disease and polycystic ovarian syndrome.
    Brzozowska MM; Ostapowicz G; Weltman MD
    J Gastroenterol Hepatol; 2009 Feb; 24(2):243-7. PubMed ID: 19215335
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metabolic characteristics of women with polycystic ovaries and oligo-amenorrhoea but normal androgen levels: implications for the management of polycystic ovary syndrome.
    Barber TM; Wass JA; McCarthy MI; Franks S
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):513-7. PubMed ID: 17371468
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cardiometabolic risk in polycystic ovary syndrome: a comparison of different approaches to defining the metabolic syndrome.
    Cussons AJ; Watts GF; Burke V; Shaw JE; Zimmet PZ; Stuckey BG
    Hum Reprod; 2008 Oct; 23(10):2352-8. PubMed ID: 18635531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The metabolic syndrome in polycystic ovary syndrome.
    Essah PA; Wickham EP; Nestler JE
    Clin Obstet Gynecol; 2007 Mar; 50(1):205-25. PubMed ID: 17304037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Polycystic ovary syndrome and the metabolic syndrome.
    Weerakiet S
    J Med Assoc Thai; 2004 Oct; 87 Suppl 3():S189-93. PubMed ID: 21213522
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and biochemical characterization of women with polycystic ovary syndrome in North Rhine-Westphalia.
    Hahn S; Tan S; Elsenbruch S; Quadbeck B; Herrmann BL; Mann K; Janssen OE
    Horm Metab Res; 2005 Jul; 37(7):438-44. PubMed ID: 16034717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Polycystic ovary syndrome and type 2 diabetes mellitus.
    De Leo V; Musacchio MC; Morgante G; La Marca A; Petraglia F
    Minerva Ginecol; 2004 Feb; 56(1):53-62. PubMed ID: 14973410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.